GB0404708D0 - Boron containing nanoparticles - Google Patents
Boron containing nanoparticlesInfo
- Publication number
- GB0404708D0 GB0404708D0 GBGB0404708.0A GB0404708A GB0404708D0 GB 0404708 D0 GB0404708 D0 GB 0404708D0 GB 0404708 A GB0404708 A GB 0404708A GB 0404708 D0 GB0404708 D0 GB 0404708D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- containing nanoparticles
- boron containing
- boron
- nanoparticles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/009—Neutron capture therapy, e.g. using uranium or non-boron material
- A61K41/0095—Boron neutron capture therapy, i.e. BNCT, e.g. using boronated porphyrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6927—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
- A61K47/6929—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0404708.0A GB0404708D0 (en) | 2004-03-02 | 2004-03-02 | Boron containing nanoparticles |
PCT/EP2005/002040 WO2005094884A2 (en) | 2004-03-02 | 2005-02-25 | Boron containing nanoparticles targeted to t-cells |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0404708.0A GB0404708D0 (en) | 2004-03-02 | 2004-03-02 | Boron containing nanoparticles |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0404708D0 true GB0404708D0 (en) | 2004-04-07 |
Family
ID=32088593
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0404708.0A Ceased GB0404708D0 (en) | 2004-03-02 | 2004-03-02 | Boron containing nanoparticles |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0404708D0 (en) |
WO (1) | WO2005094884A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2460689C1 (en) | 2011-06-21 | 2012-09-10 | Закрытое акционерное общество "Институт прикладной нанотехнологии" | Method of making boron-silicon-containing nanoparticles |
CA3139733A1 (en) * | 2019-05-31 | 2021-01-07 | Michigan Technological University | High-brightness nanodot fluorophores by covalent functionalization |
RU2720458C1 (en) * | 2019-06-06 | 2020-04-30 | Автономное некоммерческое объединение "Международный научно-исследовательский центр инновационных технологий" (АНО "МНИЦИТ МАРТИНЕКС") | Method of producing a composition for boron-neutron capture therapy of malignant tumors (versions) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0007088D0 (en) * | 2000-03-23 | 2000-05-17 | Torsana A S | Detection of immunological memory determining the position of loci of pathologyand therapeutic t-cell conjugates |
DE10154830A1 (en) * | 2001-11-08 | 2003-06-12 | Deutsches Krebsforsch | Conjugate for BNC therapy of radiation-resistant tumors |
GB2383534A (en) * | 2001-12-28 | 2003-07-02 | Psimei Pharmaceuticals Plc | Delivery of neutron capture elements for neutron capture therapy |
GB0222945D0 (en) * | 2002-10-03 | 2002-11-13 | Psimei Pharmaceuticals Plc | Therapeutic compositions |
-
2004
- 2004-03-02 GB GBGB0404708.0A patent/GB0404708D0/en not_active Ceased
-
2005
- 2005-02-25 WO PCT/EP2005/002040 patent/WO2005094884A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2005094884A3 (en) | 2007-05-10 |
WO2005094884A2 (en) | 2005-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2472542B (en) | Nanoparticles | |
EP1773679A4 (en) | Packages | |
GB0516254D0 (en) | Improvements in devices | |
EP1915381A4 (en) | Boron compounds useful in bnct | |
GB0414278D0 (en) | Nanoparticles | |
GB0404708D0 (en) | Boron containing nanoparticles | |
DE602005024518D1 (en) | C10-cyclopentylester-substituierte taxane | |
GB2416348B (en) | Carrying case | |
GB0423740D0 (en) | Nanostructures | |
GB2412899B (en) | Wheelbarrow | |
EP1814423A4 (en) | Carrying harness | |
GB0513575D0 (en) | Carrying device | |
GB0407915D0 (en) | Nanoparticles | |
GB0407603D0 (en) | Nanoparticles | |
GB0410522D0 (en) | Functionaliseable nanoparticles | |
AU158466S (en) | Carrier | |
GB0405719D0 (en) | Carrier | |
PL364312A1 (en) | Conveying-masking carrier | |
GB0506870D0 (en) | Nanoparticles | |
GB0507299D0 (en) | Nanoparticles | |
GB0501834D0 (en) | How gravity works | |
GB2425049B (en) | Carrying device | |
GB0323383D0 (en) | Nanoparticles | |
GB0408203D0 (en) | Functionaliseable nanoparticles | |
GB0401903D0 (en) | Easy carrier |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |